Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katy Cooper

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
European Urology Focus|July 20, 2017
Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysisMarrissa Martyn-St James, Katy Cooper, Shijie Ren, et al.
Health Technology Assessment (Winchester, England)|July 3, 2019
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysisSue Harnan, Paul Tappenden, Katy Cooper, et al.
Health Technology Assessment (Winchester, England)|October 11, 2025
Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review and economic evaluationPaul Tappenden, Katy Cooper, Jean Hamilton, et al.
Breast Cancer Research and Treatment|February 3, 2025
Gene expression profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic reviewKaty Cooper, Gamze Nalbant, Munira Essat, et al.
The British Journal of Ophthalmology|February 13, 2019
Dexamethasone implant for non-infectious uveitis: is it cost-effective?Hazel Squires, Iñigo Bermejo, Edith N Poku, et al.
The British Journal of Ophthalmology|February 8, 2019
Adalimumab for non-infectious uveitis: is it cost-effective?Inigo Bermejo, Hazel Squires, Edith N Poku, et al.
BMC Health Services Research|August 4, 2022
Cost-effectiveness of transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis of intermediate surgical risk in SingaporeRachel Su-En See-Toh, Xin Yi Wong, Kush Shiv Kishore Herkshin Mahboobani, et al.
Health Technology Assessment (Winchester, England)|January 6, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-frameworkPeter Murphy, David Glynn, Sofia Dias, et al.
BMJ Open|September 11, 2020
What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluationChloe Thomas, Alan Brennan, Edward Goka, et al.
Health Technology Assessment (Winchester, England)|September 27, 2025
Quantitative faecal immunochemical tests to guide colorectal cancer pathway referral in primary care. A systematic review, meta-analysis and cost-effectiveness analysisSue Harnan, Aline Navega Biz, Jean Hamilton, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Urology Focus|July 20, 2017
Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysisMarrissa Martyn-St James, Katy Cooper, Shijie Ren, et al.
Health Technology Assessment (Winchester, England)|July 3, 2019
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysisSue Harnan, Paul Tappenden, Katy Cooper, et al.
Health Technology Assessment (Winchester, England)|October 11, 2025
Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review and economic evaluationPaul Tappenden, Katy Cooper, Jean Hamilton, et al.
Breast Cancer Research and Treatment|February 3, 2025
Gene expression profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic reviewKaty Cooper, Gamze Nalbant, Munira Essat, et al.
The British Journal of Ophthalmology|February 13, 2019
Dexamethasone implant for non-infectious uveitis: is it cost-effective?Hazel Squires, Iñigo Bermejo, Edith N Poku, et al.
The British Journal of Ophthalmology|February 8, 2019
Adalimumab for non-infectious uveitis: is it cost-effective?Inigo Bermejo, Hazel Squires, Edith N Poku, et al.
BMC Health Services Research|August 4, 2022
Cost-effectiveness of transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis of intermediate surgical risk in SingaporeRachel Su-En See-Toh, Xin Yi Wong, Kush Shiv Kishore Herkshin Mahboobani, et al.
Health Technology Assessment (Winchester, England)|January 6, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-frameworkPeter Murphy, David Glynn, Sofia Dias, et al.
BMJ Open|September 11, 2020
What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluationChloe Thomas, Alan Brennan, Edward Goka, et al.
Health Technology Assessment (Winchester, England)|September 27, 2025
Quantitative faecal immunochemical tests to guide colorectal cancer pathway referral in primary care. A systematic review, meta-analysis and cost-effectiveness analysisSue Harnan, Aline Navega Biz, Jean Hamilton, et al.
Pageof 6